Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) were down 2.1% during mid-day trading on Monday . The stock traded as low as $13.81 and last traded at $13.86, with a volume of 1,626,036 shares changing hands. The stock had previously closed at $14.16.

Several analysts have recently issued reports on MDRX shares. Zacks Investment Research lowered shares of Allscripts Healthcare Solutions from a “buy” rating to a “sell” rating in a research report on Wednesday, April 20th. Canaccord Genuity reiterated a “buy” rating and issued a $18.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, May 6th. KeyCorp restated a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Sunday, May 22nd. FBR & Co restated a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Wednesday, June 29th. Finally, Goldman Sachs Group Inc. boosted their price target on shares of Allscripts Healthcare Solutions from $14.00 to $16.00 and gave the stock a “neutral” rating in a research report on Friday. Eleven analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $16.08.

The firm has a 50 day moving average of $13.52 and a 200 day moving average of $13.23. The firm has a market cap of $2.60 billion and a PE ratio of 928.00.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.14 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.14. During the same period in the previous year, the company posted $0.12 earnings per share. The business earned $386.50 million during the quarter, compared to analyst estimates of $403.13 million. Allscripts Healthcare Solutions’s revenue was up 2.9% on a year-over-year basis. On average, analysts predict that Allscripts Healthcare Solutions Inc. will post $0.59 earnings per share for the current year.

In related news, CEO Paul Black sold 15,000 shares of the stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $13.04, for a total value of $195,600.00. Following the sale, the chief executive officer now directly owns 1,197,329 shares of the company’s stock, valued at approximately $15,613,170.16. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Dennis Olis sold 7,000 shares of the stock in a transaction dated Monday, July 11th. The shares were sold at an average price of $14.00, for a total transaction of $98,000.00. Following the completion of the sale, the senior vice president now directly owns 210,887 shares in the company, valued at $2,952,418. The disclosure for this sale can be found here.

Other large investors have modified their holdings of the company. Broadview Advisors LLC boosted its stake in shares of Allscripts Healthcare Solutions by 1.9% in the fourth quarter. Broadview Advisors LLC now owns 1,148,350 shares of the company’s stock worth $17,662,000 after buying an additional 21,100 shares during the last quarter. Airain ltd boosted its stake in Allscripts Healthcare Solutions by 440.2% in the fourth quarter. Airain ltd now owns 161,462 shares of the company’s stock valued at $2,483,000 after buying an additional 131,572 shares in the last quarter. Systematic Financial Management LP purchased a new stake in Allscripts Healthcare Solutions during the fourth quarter valued at about $1,814,000. Finally, Principal Financial Group Inc. boosted its stake in Allscripts Healthcare Solutions by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 608,152 shares of the company’s stock valued at $9,353,000 after buying an additional 14,595 shares in the last quarter.

Allscripts Healthcare Solutions, Inc delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.